Chung‐Yin Lin

2.0k citations
41 papers · 1.6k indexed · h-index 21

Chung‐Yin Lin

40 papers receiving 1.5k citations

Peers

Chung‐Yin Lin
Comparison fields: 5 of 109
  • Biomedical Engineering 1.0k
  • Analytical Chemistry 203
  • Biomaterials 220
  • Radiology, Nuclear Medicine and Imaging 287
  • Neurology 84
Replace Hans‐Ulrich Gremlich with:
Hans‐Ulrich Gremlich Switzerland
Nikita Navolokin Russia
Ping Dai China
Dimitrios Psimadas Greece
Barbara Cacciari Italy
E. Frigerio Italy
Zulfiya Orynbayeva United States
Oxana Klementieva Sweden
Chulhyun Lee South Korea
Vijaykumar Sutariya United States
Chung‐Yin Lin relative to Hans‐Ulrich Gremlich Switzerland Hans‐Ulrich Gremlich's profile →
Citations per field
00.5×9.7×
Hans‐Ulrich Gremlich · 1×
Citations per year

Countries citing papers authored by Chung‐Yin Lin

Since Specialization
Citations

This map shows the geographic impact of Chung‐Yin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung‐Yin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung‐Yin Lin more than expected).

Fields of papers citing papers by Chung‐Yin Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chung‐Yin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung‐Yin Lin. The network helps show where Chung‐Yin Lin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Chung‐Yin Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chung‐Yin Lin Line = papers co-authored together Chung‐Yin Lin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 202318
3 202315
4 20234
5 20221
6 20221
7 202114
8 202127
9 202014
10 201815
11 2016128
12 201695
13 2016127
14 20165
15 201595
16 201380
17 201246
18 201050
19 201035
20 200338

About Chung‐Yin Lin

Chung‐Yin Lin is a scholar working on Biological Psychiatry, Analytical Chemistry and Biomedical Engineering, having authored 41 papers that have together received 1.6k indexed citations. Recurring topics across this work include Ultrasound and Hyperthermia Applications (17 papers), Photoacoustic and Ultrasonic Imaging (9 papers), Ultrasound and Cavitation Phenomena (6 papers), Analytical chemistry methods development (6 papers), Parkinson's Disease Mechanisms and Treatments (5 papers), Nanoplatforms for cancer theranostics (4 papers), Alzheimer's disease research and treatments (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). The work is most often cited by research in Biomedical Engineering (1.0k citations), Analytical Chemistry (203 citations) and Biomaterials (220 citations). Chung‐Yin Lin has collaborated with scholars based in Taiwan, United States and Malaysia. Frequent co-authors include Hao-Li Liu, Dar‐Fu Tai, William G. Pitt, Chih‐Kuang Yeh, Tzong-Zeng Wu, Kuo‐Chen Wei, Li‐Kuang Chen, Win-Li Lin, Chiung‐Mei Chen and Ching‐Hsiang Fan. Their work appears in journals such as PLoS ONE, Analytical Chemistry and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026